Rivastigmine tartrate is the generic ingredient in two branded drugs marketed by Novartis, Alembic Pharms Ltd, Apotex Inc, Dr Reddys Labs Inc, Macleods Pharms Ltd, Sun Pharm Inds, and Watson Labs, and is included in eight NDAs. There is one patent protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
There are twenty-seven drug master file entries for rivastigmine tartrate. Three suppliers are listed for this compound. There are two tentative approvals for this compound.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
Alembic Pharms Ltd
|CAPSULE;ORAL||091689||Jun 12, 2012||RX||No||<disabled>||<disabled>|
Macleods Pharms Ltd
|CAPSULE;ORAL||203148||Aug 22, 2014||RX||No||<disabled>||<disabled>|
Dr Reddys Labs Inc
|CAPSULE;ORAL||077130||Oct 31, 2007||RX||No||<disabled>||<disabled>|
|CAPSULE;ORAL||091072||May 16, 2013||RX||No||<disabled>||<disabled>|
Sun Pharm Inds
|CAPSULE;ORAL||077131||Oct 22, 2007||RX||No||<disabled>||<disabled>|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.